PubRank

Mark A Jenkins

Author PubWeight™ 163.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 2002 3.46
2 The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 2008 3.35
3 Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 2005 3.19
4 Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat Genet 2012 3.19
5 Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst 2013 3.06
6 A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 2011 2.96
7 Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 2003 2.84
8 Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012 2.77
9 Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology 2012 2.57
10 Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 2009 2.56
11 Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet 2011 2.47
12 Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst 2012 2.44
13 Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet 2011 2.35
14 Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 2010 2.30
15 Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 2011 2.29
16 Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol 2012 2.22
17 Telomere length varies by DNA extraction method: implications for epidemiologic research. Cancer Epidemiol Biomarkers Prev 2013 2.14
18 Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev 2008 2.12
19 Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer. Cancer Prev Res (Phila) 2010 2.08
20 Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 2005 2.03
21 Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res 2007 2.02
22 Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 2010 1.99
23 The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology 2010 1.88
24 Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol 2012 1.88
25 Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications? Med J Aust 2009 1.81
26 Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer 2011 1.76
27 Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev 2009 1.72
28 Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 2008 1.69
29 Colon and rectal cancer survival by tumor location and microsatellite instability: the Colon Cancer Family Registry. Dis Colon Rectum 2013 1.65
30 Molecular screening of all colorectal tumors diagnosed before age 50 years followed by genetic testing efficiently identifies Lynch syndrome cases. Int J Cancer 2009 1.56
31 Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 2013 1.55
32 Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut 2012 1.52
33 Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Mod Pathol 2013 1.47
34 Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat Genet 2011 1.46
35 Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev 2008 1.36
36 Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One 2010 1.36
37 Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics. Hum Mutat 2009 1.35
38 Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Int J Epidemiol 2012 1.33
39 Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes. Hum Mol Genet 2011 1.33
40 Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics. Hum Genet 2003 1.32
41 Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res 2010 1.32
42 Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res 2003 1.28
43 Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis 2010 1.27
44 Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. J Mol Diagn 2011 1.27
45 Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study. Am J Epidemiol 2009 1.27
46 Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev 2011 1.22
47 Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol 2004 1.20
48 A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet 2013 1.17
49 BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome. Am J Surg Pathol 2013 1.16
50 A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry. Hum Mutat 2012 1.14
51 PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival. PLoS One 2013 1.13
52 Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer 2011 1.10
53 Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Clin Cancer Res 2007 1.10
54 Is the reported modifying effect of 8q23.3 and 11q23.1 on colorectal cancer risk for MLH1 mutation carriers valid? Int J Cancer 2013 1.09
55 Mutation deep within an intron of MSH2 causes Lynch syndrome. Fam Cancer 2011 1.09
56 Risk of breast cancer in Lynch syndrome: a systematic review. Breast Cancer Res 2013 1.08
57 Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 2006 1.08
58 Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol 2007 1.08
59 Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res 2005 1.07
60 BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev 2006 1.07
61 Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010 1.07
62 Family history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer cases. Cancer Epidemiol Biomarkers Prev 2013 1.05
63 Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res 2010 1.05
64 Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Mod Pathol 2013 1.04
65 Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn 2010 1.04
66 Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol 2013 1.03
67 Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol 2012 1.00
68 Infrapectineal plating for acetabular fractures: a technical adjunct to internal fixation. J Orthop Trauma 2004 1.00
69 Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years. Eur J Cancer 2006 1.00
70 Factors influencing asthma remission: a longitudinal study from childhood to middle age. Thorax 2011 0.99
71 Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis. Fam Cancer 2011 0.97
72 Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis. Fam Cancer 2013 0.96
73 Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol 2015 0.96
74 Genome-wide search for gene-gene interactions in colorectal cancer. PLoS One 2012 0.96
75 Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol 2011 0.95
76 Screening practices of unaffected people at familial risk of colorectal cancer. Cancer Prev Res (Phila) 2011 0.95
77 Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer. Epigenetics 2013 0.94
78 Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2014 0.94
79 Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22. PLoS One 2012 0.93
80 Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E. PLoS One 2013 0.93
81 No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years. Cancer Epidemiol Biomarkers Prev 2006 0.93
82 Who remembers whether they had asthma as children? J Asthma 2006 0.92
83 Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? Eur J Cancer 2013 0.92
84 Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut 2013 0.92
85 Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer Causes Control 2009 0.92
86 Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. Am J Surg Pathol 2013 0.91
87 Sociodemographic, lifestyle, and medical risk factors for visual impairment in an urban asian population: the singapore malay eye study. Arch Ophthalmol 2009 0.90
88 Is childhood immunisation associated with atopic disease from age 7 to 32 years? Thorax 2006 0.90
89 Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes. Hum Mutat 2011 0.89
90 Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). Breast Cancer Res Treat 2009 0.88
91 Determining the frequency of de novo germline mutations in DNA mismatch repair genes. J Med Genet 2011 0.88
92 Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry. Cancer Prev Res (Phila) 2011 0.88
93 Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. Cancer Epidemiol Biomarkers Prev 2013 0.88
94 Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer. Cancer Epidemiol 2013 0.88
95 Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK. J Med Genet 2011 0.87
96 Does eczema in infancy cause hay fever, asthma, or both in childhood? Insights from a novel regression model of sibling data. J Allergy Clin Immunol 2012 0.87
97 Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases. Genet Med 2012 0.87
98 Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis. Fam Cancer 2009 0.87
99 Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome). Fam Cancer 2011 0.87
100 Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer 2010 0.86
101 Criteria and prediction models for mismatch repair gene mutations: a review. J Med Genet 2013 0.86
102 MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study. Int J Cancer 2012 0.86
103 MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study. BMC Cancer 2013 0.86
104 Investigating the potential role of genetic and epigenetic variation of DNA methyltransferase genes in hyperplastic polyposis syndrome. PLoS One 2011 0.85
105 Screening participation predictors for people at familial risk of colorectal cancer: a systematic review. Am J Prev Med 2013 0.85
106 Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer. Cancer Causes Control 2012 0.85
107 Early-life sun exposure and risk of melanoma before age 40 years. Cancer Causes Control 2011 0.85
108 Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry. Mod Pathol 2012 0.84
109 Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013 0.84
110 Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. J Clin Oncol 2007 0.83
111 High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry. Fam Cancer 2014 0.83
112 Cost-effectiveness of family history-based colorectal cancer screening in Australia. BMC Cancer 2014 0.83
113 Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Fam Cancer 2013 0.83
114 Estimates of familial risks from family data are biased when ascertainment of families is not independent of family history. Gut 2010 0.82
115 Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010 0.82
116 A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer. Hum Mutat 2005 0.81
117 Asthma, asthma medications, and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2010 0.81
118 Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry. PLoS One 2013 0.81
119 CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. Breast Cancer Res 2005 0.79
120 Childhood immunization and atopic disease into middle-age--a prospective cohort study. Pediatr Allergy Immunol 2009 0.79
121 Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer? Breast Cancer Res Treat 2007 0.79
122 The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women. Breast Cancer Res Treat 2007 0.77
123 Prostate screening uptake in Australian BRCA1 and BRCA2 carriers. Hered Cancer Clin Pract 2007 0.77
124 A range of simple summary genome-wide statistics for detecting genetic linkage using high density marker data. Genet Epidemiol 2007 0.76
125 Stability of BAT26 in Lynch syndrome colorectal tumours. Eur J Hum Genet 2006 0.76
126 Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry. Genes Chromosomes Cancer 2014 0.76
127 Letter in response to "Identifying Lynch syndrome" by de la Chapelle et al. Int J Cancer 2010 0.75
128 Response. J Natl Cancer Inst 2013 0.75
129 Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins. Mod Pathol 2013 0.75
130 Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer. Am J Epidemiol 2017 0.75